Evidence map›Paper›PMID 41097705›Full record

ArticleCancers2025

Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines.

Michael Chen, Thomas Kane, Ina Chen, Suangson Supabphol, Xiuli Zhang, Alexandra A Wolfarth, Donghoon Choi, Lijin Li, S Peter Goedegebuure, William E Gillanders

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael ChenDepartment of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Thomas KaneDepartment of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0009-0005-2916-1427
Ina ChenDepartment of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Suangson SupabpholDepartment of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Xiuli ZhangDepartment of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Alexandra A WolfarthNeoImmuneTech, Inc., Rockville, MD 20850, USA.
Donghoon ChoiNeoImmuneTech, Inc., Rockville, MD 20850, USA.
Lijin LiDepartment of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0001-6203-8854
S Peter GoedegebuureDepartment of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.
William E GillandersDepartment of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.

Funding

Targeting Neoantigens in Triple Negative Breast CancerR01CA240983 · NCI · WASHINGTON UNIVERSITY · PI GILLANDERS, WILLIAM E., SCHREIBER, ROBERT DAVID · 2019 to 2023
$3.2M
Foundation for Barnes-Jewish Hospital B5138-80NCI NIH HHS R01 CA240983NIH HHS 1P30CA091842-27NIH HHS 1R01CA240983-25NIH HHS 1T32CA009621-26
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerDNA vaccineimmune responseneoantigenrecombinant IL-7

Identifiers

PMID41097705
PMCPMC12523240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.